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RESEARCH ARTICLE

Perturbed mitochondria–ER contacts in live neurons that model
the amyloid pathology of Alzheimer’s disease

ABSTRACT
The use of fixed fibroblasts from familial and sporadic Alzheimer’s
disease patients has previously indicated an upregulation of
mitochondria–ER contacts (MERCs) as a hallmark of Alzheimer’s
disease. Despite its potential significance, the relevance of these
results is limited because they were not extended to live neurons. Here
we performed a dynamic in vivo analysis of MERCs in hippocampal
neurons from McGill-R-Thy1-APP transgenic rats, a model of
Alzheimer’s disease-like amyloid pathology. Live FRET imaging of
neurons from transgenic rats revealed perturbed ‘lipid-MERCs’ (gap
width <10 nm), while ‘Ca2+-MERCs’ (10–20 nm gap width) were
unchanged. In situ TEM showed no significant differences in the lipidMERCs:total MERCs or lipid-MERCs:mitochondria ratios; however, the
average length of lipid-MERCs was significantly decreased in neurons
from transgenic rats as compared to controls. In accordance with FRET
results, untargeted lipidomics showed significant decreases in levels of
12 lipids and bioenergetic analysis revealed respiratory dysfunction of
mitochondria from transgenic rats. Thus, our results reveal changes in
MERC structures coupled with impaired mitochondrial functions in
Alzheimer’s disease-related neurons.
This article has an associated First Person interview with the first author
of the paper.
KEY WORDS: Alzheimer, Transgenic rats, Amyloid β/βCTF, Primary
neuronal cultures, MERC, Mitochondrial lipids, FRET

INTRODUCTION

Despite a plethora of studies that date back more than two decades,
the early mechanisms that associate accumulation of amyloid β (Aβ)
with neuronal dysfunction in Alzheimer’s disease have not been
elucidated. However, bioenergetic failure has been suggested as an
early event responsible for neuronal death in Alzheimer’s disease
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(Leuner et al., 2007; Mancuso et al., 2007; Mosconi et al., 2009;
Kapogiannis and Mattson, 2011). It has been shown that amyloid β
precursor protein (APP) and Aβ colocalize with mitochondria (Devi
and Ohno, 2012; Hansson Petersen et al., 2008), that Aβ inhibits
respiratory chain function (reviewed in Swerdlow, 2012) and that
mitochondrial function also changes APP processing increasing or
decreasing the production of amyloidogenic derivatives (Gabuzda
et al., 1994; Gasparini et al., 1997; Leuner et al., 2012; Pereira et al.,
1998). Apart from their essential role in bioenergetics, mitochondria
are also involved in a great variety of other cellular processes, such
as Ca2+ homeostasis and lipid biosynthesis. These functions require
a dynamic spatial organization that allows signaling from and to
other organelles. In particular, mitochondria are associated with the
endoplasmic reticulum (ER) – i.e. the mitochondria–ER contacts
(MERCs) – form between the outer mitochondrial membrane
(OMM) and specialized regions of the ER, in which membrane and
luminal components can intermix and exchange (Shore and Tata,
1977; Vance, 1990). These membranes can run in juxtaposition for
hundreds of nanometers with a gap width of 5–30 nm between them
when mitochondria are associated with smooth ER. The number of
contacts, the interface length and the gap width are parameters
regulated by the cell and may vary depending on the metabolic
needs and the presence of stress agents (Bravo et al., 2011; Csordás
et al., 2006; Sood et al., 2014).
Although many studies have investigated MERCs in Alzheimer’s
disease, none has analyzed in detail their number, interface length and
structure within primary neurons in vivo. Moreover, not much
attention has been paid to the gap width between a mitochondrion and
the ER, an important structural parameter that regulates the function
of MERCs in the transfer of ions and molecules between organelles
(reviewed in Csordás et al., 2018; Giacomello and Pellegrini, 2016).
It has, however, been shown that mitochondria can capture and
accumulate Ca2+ to regulate the activity of enzymes that are central in
energetic metabolism (Rizzuto et al., 2012; Hajnóczky et al., 1995;
Jouaville et al., 1999; McCormack et al., 1990). The uptake of Ca2+
by the mitochondrial Ca2+ uniporter (MCU) (Baughman et al., 2011;
De Stefani et al., 2011) – although possible without the physical
coupling of the ER to a mitochondrion – is favored when the ER
membrane is facing the OMM with a gap width of ∼15 nm (Csordás
et al., 2006, 2010). For efficient Ca2+ transfer, the organelles would
have to be separated by 10–25 nm (Ca2+-MERC). In contrast, when
lipids are being synthesized and exchanged in MERCs (lipidMERCs), the organelles need their membranes to be in close
proximity. Assuming that the density of the enzymes that synthesize
lipids in these structures is homogeneous, any increase or decrease in
the MERCs area should be accompanied by a similar change in the
amount of lipids synthesized. Two models have been proposed to
explain the transport of lipids between the two membranes. The first
states that lipids are transported by hydrophobic protein complexes.
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This transport would be interrupted when the width of the
mitochondria–ER gap increases. The second model suggests that
lipids are coated by transporter proteins that diffuse from one
membrane to the other. In this case, the increased in gap width would
impact on the rate of delivery. In any case, the gap width required for
lipid transfer is expected to be as narrow as ≤10 nm, given the proposed
molecular mechanism implicated in the transfer of largely hydrophobic
molecules between the organelles (Schauder et al., 2014).
In the last few years, studies in which cell lines or fibroblasts from
Alzheimer’s disease patients (Area-Gomez et al., 2012; Del Prete
et al., 2017) or zebrafish neuronal progenitors (Newman et al.,
2017) were used, have reported alterations in MERCs, with
contradictory results (both increases and decreases). However,
none had analyzed the gap width between organelles in live
neurons, or used methods to evaluate proximity with the appropriate
resolution. Moreover, the biochemical impact of altered MERCs in
primary neurons expressing endogenous Aβ has not yet been
reported. We performed dynamic and ultrastructural analysis of
hippocampal neurons from wild-type (WT) and McGill-R-Thy1APP transgenic rats, using multicolor live imaging, Förster
resonance energy transfer (FRET) to generate drug-inducible
interorganellar linkers (lateral resolution 8–10 nm) and in situ
transmission electron microscopy (TEM).
RESULTS
Neuronal expression of human Aβ peptides leads to timedependent morphological alterations in mitochondria and
endoplasmic reticulum

Neurons from McGill-R-Thy1-APP transgenic rats express the
entire coding region of the human APP751 cDNA, including the
familial Alzheimer’s disease Swedish double mutation (K670N,
M671L) and the Indiana mutation (V717F) (Leon et al., 2010). We
first determined in the conditioned medium of days in vitro (DIV) 7
and DIV14 cultures (Fig. S1) the time-course accumulation of the
three human Aβ isoforms, and found that Aβ38, Aβ40 and Aβ42
were detectable (Fig. 1A). The mean value of the extracellular levels
of Aβ40 and of Aβ42 was substantially lower at DIV7 (2.13±0.5 pM
and 0.63±0.2 pM, respectively) and DIV14 (16.77±4.92 pM and
4.47±1.2 pM, respectively) than values previously reported in
Swedish-type APP-HEK 293 transfected cells (∼400 pM for Aβ40
and ∼10 pM for Aβ42; Ohshima et al., 2018). This reinforces the
use of this model to decipher cellular mechanisms involved in early
stages of Aβ pathology. In agreement with what was described in
cell culture experiments (Ohshima et al., 2018), Aβ monomers were
not detected in cell lysates of neurons from transgenic rats by
ELISA, suggesting an efficient clearance mechanism that precludes
intraneuronal Aβ accumulation. To evaluate the impact of
endogenous Aβ accumulation on neuronal ultrastructure, we
performed TEM analysis. To avoid disturbances in the subcellular
organization, TEM was carried out on neurons adhered to
coverslips. At DIV7, the morphology of neurons from transgenic
rats was similar to that of WT neurons; whereas at DIV14, when the
highest Aβ concentration was detected in the conditioned medium,
neurons from transgenic (Tg) rats (hereafter referred to as Tg neurons)
exhibited mitochondria with fragmented cristae and ER swelling
(Fig. 1B). Notice that, at DIV7, the number of mitochondria per soma
(Fig. 1C) and the ER lumen area (Fig. 1D) were not significantly
different between genotypes. However, at DIV14, an increase in the
ER lumen area was detected compared to DIV7 neurons – regardless
the presence of the human transgene.
To then assess whether levels of soluble Aβ isoforms detected in
DIV7 Tg neurons are associated with changes in the composition of
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endogenous free fatty acids (FFAs), which are known to modulate
organelle membrane fluidity, oxidative stress and inflammation
(Wang et al., 2012) we applied liquid chromatography-mass
spectrometry (LC-MS) to DIV7 WT and Tg neurons. Six FFAs
were detected across the neuron samples, with palmitic acid, oleic
acid and stearic acid being by far the most abundant ones and
roughly equal in concentration. A multiple t-test comparison was
carried out between WT and Tg neurons, but no significant
(P<0.05) differences of any of the FFAs were observed (Table S1).
Live Tg neurons exhibit decreased coupling in lipid-MERC

To perform an in vivo analysis of neuronal MERCs at early stages of
Aβ pathology, without morphological alterations of mitochondria or
ER and in the absence of disturbed lipid metabolism, we studied
pre-existing physiological- MERCs in live hippocampal neurons
from WT and Tg rats at DIV7. For this, we employed inducible
interorganellar linkers tagged with CFP or YFP, which allow the
measurement of mitochondria–ER coupling in living cells at a
resolution of 8–10 nm. We transfected neurons with rapamycininducible synthetic interorganellar linkers and, upon expression of
these constructs and following addition of rapamycin, a ‘bridge
formation’ was induced at the areas where ER and OMM are
naturally close. CFP and YFP formed a FRET pair, and the FRET
signal confined to the mitochondria–ER interface was visualized by
multicolor epifluorescence microscopy. Rapamycin was applied
only for a short time (<8 min) to minimize the broad effects initiated
through its endogenous receptor mTOR (Kim and Guan, 2015).
Addition of rapamycin led to immediate increase of the FRET signal
and to a decrease in CFP fluorescence in both WT and Tg neuronal
somata. In WT neurons, the FRET:CFP ratio rapidly rose in a linear
way until reaching a plateau at 200 s (short linkers) (Fig. 2A) or
150 s (long linkers) (Fig. 2B). Both WT and Tg neurons exhibited a
similar FRET:CFP ratio with long linkers along the measurement
(Fig. 2B) while with short linkers, the curve was linear during all its
trajectory without reaching a plateau (Fig. 2A), indicating decreased
mitochondria–ER coupling at a gap width of <10 nm.
Fixed Tg neurons display similar percentages of lipid-MERCs
but decreased length of appositions

To further test the mitochondria–ER interface, TEM images were
quantified using an in-house-developed macro for the imageprocessing package Fiji (Weaver et al., 2017). Following the same
methodology as was used for the live FRET imaging, fixation was
performed on cells attached to coverslips to conserve the characteristic
morphology of the neurons. The analysis revealed that the percentage
of lipid-MERCs versus total MERCs (Fig. 2C) and the percentage of
lipid-MERCs versus total number of mitochondria (Fig. 2D) was
similar between genotypes. However, we found that the length of ERmitochondrial appositions (Sood et al., 2014) with a gap width of
<10 nm (lipid-MERC) was significantly reduced in Tg as compared to
WT neurons (Fig. 3B). Since the decreased length of appositions in Tg
neurons could be the consequence of decreased mitochondria size, we
quantified the perimeter of mitochondria from WT and Tg neurons, and
found no significant differences between groups (Fig. 3C). Moreover,
the decrease in the interface length of appositions in lipid-MERCs
of Tg neurons persisted after normalizing it to the perimeter of
mitochondria (Fig. 3D), suggesting that reduced length of appositions
in lipid-MERCs of Tg rats is not a consequence of altered mitochondrial
morphology. Representative TEM micrographs depicting the interface
length in WT and Tg rats are shown in Fig. 3E. Thus, both the
FRET and ultrastructure measurements support our finding that the tight
lipid-MERCs are reduced in Tg neurons.
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Fig. 1. Hippocampal primary neurons from transgenic rats produce human Aβ isoforms, and show mitochondria and endoplasmic reticulum swelling
after DIV14. (A) Quantification of Aβ levels in the conditioned media of hippocampal primary neurons. Bar graphs show the concentration (in pM) of each Aβ
isoform in Tg neurons at DIV7 or DIV14 from three different independent cultures and genotype. Unpaired two-tailed Student’s t-test (Aβ38: P=0.610; Aβ40:
P=0.040; Aβ42: P=0.035) was used to compare between DIV data. (B) Representative TEM images showing mitochondria (Mt) and ER ultrastructures in
coverslip-attached embryonic primary hippocampal neurons from WT rats at DIV7 (top left panel) and DIV14 (bottom left panel), and in Tg neurons at DIV7 (top
right panel) or DIV14 (bottom right panel). Scale bar: 250 nm. (C) Quantification of mitochondria (Mt) number in neuronal somata. For each genotype three
independent hippocampal primary neuronal cultures were used, with 10–12 embryos per culture. Data were obtained after TEM analysis of coverslip-attached
primary cultures from WT and Tg rats at DIV7 or DIV14. WT DIV7: n=9 cells; Tg DIV7: n=9 cells; WT DIV14: n=4 cells; Tg DIV14: n=8 cells. Two-way ANOVA test
was used to make comparisons among the means of the four groups of data, where two independent variables (DIV and Genotype) were considered. The ANOVA
result is reported as an F-statistic and its associated degrees of freedom and P-value. The effect of DIV (F1,26=0.1, P=0.749) or Genotype (F1,26=0.78, P=0.385)
were not considered significant, neither was the interaction DIV×Genotype (F1,26=0.15, p=0.704). (D) Quantification of ER lumen area in the same neuronal
somata as used in C. Kruskal–Wallis test (P<0.0001) followed by Dunn’s post-hoc test. ***P<0.001. In the box-and-whisker plots in C,D, the box represents the
25–75th percentiles, the median is indicated with a line and the mean with ’+’. The whiskers show the minimum and maximum values.
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Decreased interface length in lipid-MERCs is associated with
alterations in mitochondrial lipid profiles and bioenergetics
functionality

To associate the decreased lipid-MERCs with a biochemical read-out,
we isolated mitochondria from primary neuronal cells of WT and Tg
rats (Fig. S2) and analyzed the lipid profile using high resolution liquid
chromatography–tandem mass spectrometery (LC-MS/MS). Lipid
peaks were identified in each sample using LipidBlast (Kind et al.,
2013), and the resulting hits were quantified using in-house scripts
(available upon request). The lipid profile of the mitochondrial extracts
showed a significant deviation in the Tg group compared with WT
(Fig. 4A). From the total number of lipids detected (n=106, Table S2),
twelve lipids were significantly different in mitochondria of Tg rats
when compared to those of WT rats (P≤0.015; Fig. 4B). Among those
lipids, we found a 60% decrease in main mitochondrial phospholipids,
i.e. cardiolipin and phosphatidylethanolamine (PtdEtn) in
mitochondria preparations from Tg neurons as compared to WT,
suggesting that alterations on lipid-MERCs directly impact on the
biological relationship of membrane composition, structure and
function in mitochondria, which can induce bioenergetic dysfunction.
In this regard, we assessed mitochondrial bioenergetics in intact
neurons by extracellular flux analysis. We found an altered
bioenergetics profile (Fig. 4C) and a significantly reduced spare
respiratory capacity (Fig. 4D) in Tg versus WT neurons, suggesting
a possible impairment in meeting a sudden increase in energy
demand with increased ATP synthesis.
DISCUSSION

According to the Aβ levels detected in Tg neuron cultures, we
speculate that our system represents a mild cellular model of
Alzheimer’s disease-like amyloid pathology. The fact that we were
unable to detect intracellular Aβ accumulation suggests that, in

embryonic primary neurons, the degradation of aggregation-prone
proteins, which are retained in the ER, is efficiently mediated by
proteasome (Kostova and Wolf, 2003) and by insulin-degrading
enzyme (Schmitz et al., 2004) activities. However, we found
morphological alterations of mitochondria and ER in Tg neurons at
DIV14, similar to those reported in brains of Alzheimer’s disease
patients (Baloyannis, 2011), suggesting that extracellular Aβ peptides
somehow impact on neuronal functionality. Mitochondrial swelling
has been associated with the pathogenesis of Alzheimer’s disease;
however, mitochondrion alterations in neurons from brains of
Alzheimer’s disease patients were not related to accumulation of
amyloid deposits (Baloyannis, 2011). Even though we did not
determine any parameter of the unfolded protein response (UPR)
response in WT and Tg neurons at DIV7 and DIV14, we speculate that
Tg neurons at DIV14 show signs of activated UPR. The induction of
artificial ER stress by overexpressing a membrane protein (as APP)
must be considered as a possibility in our experimental setting, as
previously reported (Hashimoto and Saido, 2018). However, the fact
that the sub-cellular structure of mitochondria and ER is conserved in
DIV7 Tg neurons and that no significant differences were observed
between genotypes for any of the six FFAs detected, suggests that the
genetic (human APP expression) and environmental (extracellular Aβ
accumulation) insults in Tg neurons at DIV7 are not enough to disturb
the function of the ER and induce ER enlargement. In this regard, it
has previously been reported that exogenous palmitic acid decreases
the expression of neurotrophic cytokines through induction of ER
stress in SH-SY5Y human neuroblastoma cells, N2a mouse
neuroblastoma cells, and cortices and hippocampi from WT
C57BL/6J mice (Marwarha et al., 2016). Regarding our cellular
model, additional experiments are required to assess whether the
significant ER enlargement detected in Tg neurons at DIV414 is
mediated by an increase of endogenous FFAs.
4
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Fig. 2. Lipid-MERCs are decreased in live
hippocampal primary neurons from transgenic
rats. (A,B) FRET to CFP ratios (FRET:CFP)
before and after linkage induction in response to
rapamycin (indicated by an arrow) in WT and Tg
neurons with short (A) or long (B) linkers, i.e. gap
width <10 nm or ∼10–20 nm, respectively.
Calculations were made for neuronal somata.
Independent hippocampal primary neuronal
cultures (n=3, WT; n=4, Tg) were performed using
10–12 embryos per culture. Data were obtained
from 9–17 cells per group. Morphometric analysis
of lipid-contact sites (<10 nm) in transmission
electron microphotographs. (C,D) Box-andwhisker plots show percentage of lipid-MERCs
(<10 nm) per total MERCs (10–30 nm; C) and
percentage of lipid-MERCs (<10 nm) per number
of mitochondria (Mt number) (D). Box represents
the 25–75th percentiles, the median is indicated
with a line and the mean with ’+’. The whiskers
show the minimum and maximum values.

Fig. 3. Tg neurons at DIV7 display decreased interface length in lipidMERCs. (A) Scheme of the structural parameters of MERCs, i.e. gap width,
mitochondrial (Mt) perimeter and interface length, which were analyzed in
coverslip-attached neurons using TEM. (B) Bar graph shows the quantification
of the interface length with a gap width <10 nm. Unpaired two-tailed Student’s
t-test with Welch’s correction (t=3.112, P=0.003). (C) Bar graph showing the
mitochondrial perimeter of the same mitochondria used in B. Data were
analyzed by unpaired two-tailed Student’s t-test (t=1.393, **P=0.168). (D) Bar
graph showing the ratio of interface length to mitochondrial perimeter (Mt
perim) using data shown in B and C, respectively. Unpaired two-tailed
Student’s t-test with Welch’s correction (t=2.804, **P=0.007) was employed.
(E) Representative microphotographs of MERCs in WT and Tg neurons. The
interface where the gap width is <10 nm is indicated by arrowheads. All
calculations were made for neuronal somata. Analysis was performed in WT
(n=13) and Tg (n=16) cells. Neurons from each genotype came from three
independent cultures using 10–12 embryos per culture. The number of
evaluated mitochondria was n=47 for WT and n=21 for Tg neurons. Cells came
from three different cultures or genotypes using 10–12 embryos per culture.
ER, endoplasmic reticulum; Mt, mitochondria; perim, perimeter. Scale bar:
100 nm.

To our knowledge, this is the first report of MERCs in live
neurons, using methods to evaluate the proximity of these
organelles with a lateral resolution of 8–10 nm. In a similar way,
other studies have employed the same synthetic linkers to evaluate
the physical extension and integrity of MERCs in different cell
lines, considering FRET signal as proportional to the extension
of the mitochondria–ER apposition. Decreased mitochondria–ER

Journal of Cell Science (2019) 132, jcs229906. doi:10.1242/jcs.229906

coupling has also been reported in caveolin-1 knockout (Sala-Vila
et al., 2016) and mitofusin-2-ablated mouse embryonic fibroblasts
(MEFs) (Naon et al., 2016), reinforcing the validity of this genetic
tool to assess altered mitochondria–ER interaction in live cells.
However, any effects the expression of synthetic linkers per se
might have, need to be taken into account in any quantification (Shi
et al., 2018).
During the last five years, MERC analysis in Alzheimer’s disease
pathology was based on TEM – a ‘static’ approach – which suggested
that an upregulated function of MERCs could induce mitochondrial
bioenergetic dysfunction. However, this experimental evidence was
never assessed in live primary neurons expressing endogenous Aβ
peptides. MERCs were evaluated in different Alzheimer’s diseaserelated models, such as PSEN1-knockout and/or PSEN2-knockout
MEFs, and fibroblasts from patients suffering from familial or
sporadic Alzheimer’s disease (Area-Gomez et al., 2012), the
neuroblastoma cell line SH-SY5Y overexpressing APP with the
Swedish familial mutation (Del Prete et al., 2017), and mouse
hippocampal primary neurons acutely exposed to synthetic Aβ
peptides in the culture medium (Hedskog et al., 2013). In contrast to
studies using these model systems, our dynamic and static results
indicate that, at early stages of Aβ/APP fragment overproduction – i.e.
without intraneuronal Aβ accumulation and conserved mitochondrion
and ER ultrastructure – there are no changes in Ca2+-MERCs, whereas
a loosening of lipid-MERC apposition is evident. In agreement with
our observations, analysis of brain biopsies from patients with
idiopathic normal pressure hydrocephalus, a neuropathology often
associated with Alzheimer’s disease, found that the presence of both
amyloid plaques and neurofibrillary tangles (pathological hallmarks
of Alzheimer’s disease) correlates with a decreased stretch of contact
between ER and mitochondria, analyzed by TEM (Leal et al., 2018).
Even though Leal and colleagues did not take into account the gap
width between the organelles or study any biochemical impact of this
alteration, their results support our observation in Alzheimer’s diseaselike neurons of a decreased interface length in lipid-MERCs with a gap
width <10 nm. In addition, fewer MERCs were reported in senescent
cells (Janikiewicz et al., 2018), supporting the assumption that our
cellular model represents not only early stages of neuronal dysfunction
associated to Alzheimer’s disease-like amyloid pathology, but also
aging.
Reasons for the differences between our results of MERC
analysis and those in previous reports using Alzheimer’s diseaserelated in vitro models are not entirely clear but might be related to
the cell type and methods used to quantify MERCs. Previously,
MERCs were evaluated in fixed fibroblasts using confocal
microscopy (lateral resolution of 250 nm) (Area-Gomez et al.,
2012; Lidke and Lidke, 2012) or in fixed Aβ-exposed primary
neurons employing a proximity ligation assay (lateral resolution of
>30 nm) (Hedskog et al., 2013). These determinations were not
performed in live cells and the techniques employed exclude an
accurate quantification of the <10–30 nm distances that define
MERCs. Even though Area-Gomez et al. analyzed the interface
length in human fibroblasts by TEM, i.e. the gold-standard to
evaluate inter-organelle distance, they did not assess the gap width
between the ER and mitochondria (Area-Gomez et al., 2012).
Finally, the results obtained by using cells lines do present –
although they are informative – limitations compared with those
from live neurons. In this regard, Newman and colleagues recently
used TEM to analyze the interface length – as previously reported
by Area-Gomez et al. (2012) in fibroblast from human subjects – in
neuronal progenitors from zebrafish embryos injected with
morpholinos against PSEN1 and/or PSEN2, and found no
5
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significant differences in PSEN1/2 knockdown cells as compared to
controls (Newman et al., 2017). This reinforces the concept that
MERC function and/or activity is cell dependent and that, although
neurons share many features found in other cell types, they possess
some special characteristics that cannot be reproduced in nondifferentiated cells. Although Hedskog et al. employed primary
mouse hippocampal neurons, the increase in MERCs detected by
confocal microscopy after acute exposure of synthetic Aβ (Hedskog
et al., 2013) might represent an artefact because Aβ affects
intracellular trafficking of mitochondria, inducing accumulation of
mitochondria in perinuclear regions – which are regions rich in ER
(De Vos et al., 2008).
It has been already proposed that disturbances of MERCs having a
gap width of <10 nm impair lipid exchange between the ER and
mitochondria (Giacomello and Pellegrini, 2016). In our current report,
we experimentally addressed this issue, using primary neuronal
cultures. It is known that mitochondria depend on the import of
certain proteins and lipids for mitochondrial membrane formation and

for maintaining cell bioenergetics. Although phosphatidylglycerol,
cardiolipin and PtdEtn are synthesized in mitochondria by
specific enzymes, phosphatidylcholine (PtdCho), phosphatidylinositol
(PtdIns), phosphatidylserine (PtdSer) and sterols need to be imported
from other organelles. The origin of most lipids imported into
mitochondria is the ER, which requires MERCs to be properly
assembled and functionally operational (Flis and Daum, 2013).
Functionally, cardiolipin and PtdEtn interact with many mitochondrial
proteins (Osman et al., 2011) and stabilize their conformation (Joshi
et al., 2012), playing a crucial role in maintaining mitochondrial
morphology. Cardiolipin, the signature lipid of mitochondria, regulates
mitochondrial bioenergetics owing to its fundamental role in functional
membrane assembly of redox complexes. Notice that, in this report, we
found that both cardiolipin levels and bioenergetics were altered in Tg
neurons, reinforcing a direct link between mitochondrial lipid
composition and functionality. Notably, mitochondria are the main
supplier of PtdEtn to other organelles (Voelker, 1984), suggesting that a
reduction of the mitochondrial PtdEtn content – as shown in Tg neuron
6
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Fig. 4. Alterations of the mitochondrial lipid profile impact on mitochondrial bioenergetics functionality in Tg neurons at DIV7. (A) Base-peak
chromatogram of detected lipids by positive (upper panel) and negative (lower panel) mode untargeted LC-MS/MS, scan range=350–2000 m/z. Lipid
retention time is shown on the x-axis while peak intensity is shown on the y-axis. Each profile represents an overlay of the samples tested (n=3 per genotype).
Numbers indicate the lipid peaks (listed below) with significant differences between WT and Tg neurons. (B) Bar graph showing the MS intensity in arbitrary
units (A.U.) of the 12 lipids in Tg neurons that exhibited significant differences with a P-value of ≤0.015. ***P<0.001, **P<0.01, *P<0.05. Peak 4, Plasmenyl-PE
36:4; Peak 5, CerP 32:4; Peak 6, PE 37:6, Peak 7, PC 34:1; Peak 8, PC 20; 0; Peak 9, DGDG 15:0. Peak 10, PC 33:5; Peak 11, PC 31:4; Peak 12, DG 31:4;
Peak 13, PI 38:4; Plasm-PE, plasmenyl-PE; PC, phosphatidylcholine; DG, diacylglycerol; PI, phosphatidylinositol; PE, phosphatidylethanolamine; CerP,
ceramide-1-phosphate; DGDG, digalactosyldiacylglycerol; CL, cardiolipin. PE, phosphatidylethanolamine (PtdEtn); PI, phosphatidylinositol (PtdIns); PC,
phosphatidylcholine (PtdCho. (C) Bioenergetic profile of DIV7 WT and Tg neurons assessed with an extracellular flux analyser. Oxygen consumption rate
(OCR) was normalized to the mean value of the four baseline measurements (100%), before the addition of inhibitors or uncoupler, and after subtraction of nonmitochondrial respiration. (D) Bar graph shows the spare respiratory capacity calculated as the difference between maximal and baseline OCR from the same
cells as used in A. Oligo, oligomycin; FCCP, carbonyl cyanide-4-phenylhydrazone. Three independent cultures per genotype were used. Paired two-tailed
Student’s t-test (t=6.479, *P=0.023) was used to compare genotypes.

samples, can impact on neuronal functionality. We also detected
significantly lower levels of PtdCho and PtdIns in Tg as compared to
WT neurons but, in contrast to cardiolipin and PtdEtn, the specific
functions of PtdCho and PtdIns are not well defined; however, their role
in the maintenance of mitochondrial functionality seems to be
indispensable (van Meer and Hoetzl, 2010). PtdCho is the most
abundant phospholipid in eukaryotic cells (van Meer et al., 2008) but,
given that mitochondria lack PtdCho-synthesizing enzymes, it is
imported from the ER. In a similar way, PtdIns is produced in the ER and
imported into mitochondria. On the whole, our results suggest that the
decreased levels of mitochondrial lipids are a consequence of perturbed
MERC apposition length.
In our model, different cellular events might be responsible for the
reduced apposition between organelles. Stoica and colleagues
proposed previously that, in cells overexpressing Tar DNA-binding
protein 43, the main pathology in amyotrophic lateral sclerosis with
associated frontotemporal dementia – i.e. the loosening of MERCs –
is a consequence of activation of glycogen synthase kinase-3β
(GSK3β), which, in turn, disrupts binding of vesicle-associated
membrane protein-associated protein B (located in the ER) to
regulator of microtubule dynamics protein 3 (resident in the OMM)
(Stoica et al., 2014). Increasing evidence suggests that dysregulation
of GSK3β is implicated in Alzheimer’s disease (DaRocha-Souto
et al., 2012), and these findings support the idea that GSK3β is
aberrantly activated by the presence of Aβ and contributes, at least in
part, to the neuronal anatomical derangement associated with Aβ
pathology itself. Another mechanism that, in our case, seems to be
less probable, is steric hindrance that could cause accumulation of Aβ
oligomers on the OMM. Although we could not detect the presence
of soluble Aβ isoforms in cell homogenates of DIV7 Tg neurons by
ELISA, we cannot rule out the presence of intracellular Aβ oligomers.
Further experiments and the use of specific ELISA kits to detect Aβ
oligomers will clarify this issue. Finally, it has been reported that, in
addition to Aβ peptides, cleavage of APP by β-secretase generates a
C-terminal APP fragment (βCTF), which was also markedly
increased in cells overexpressing the Swedish mutant APP
(eightfold increase as compared to WT APP) (Forman et al., 1997).
Accumulation of βCTF impacts on brain microsomes and
mitochondrial function (Kim et al., 1998; Chang and Suh, 2005),
cellular events that may cause disturbances, ultimately leading to
inappropriate organelle coupling. In addition, an alternative cause of
an incompetent interaction between organelles may be the lipid
composition of the membranes. In this regard, Grimm and colleagues
reported previously that the control of cellular cholesterol and
sphingomyelin metabolism involves APP processing, and that Aβ42
directly activates neutral sphingomyelinases and downregulates
levels of sphingomyelin, whereas Aβ40 reduces de novo synthesis
of cholesterol by inhibiting the activity of 3-hydroxy-methylglutarylCoA reductase (Grimm et al., 2005).
Collectively, our results advance the current knowledge about the
organization of MERCs in neurons at early stages of Alzheimer’s
disease-like amyloid pathology, which will help to interpret
functional roles of MERC axes in the context of Alzheimer’s
disease.
MATERIALS AND METHODS
Ethical statements

This study was carried out in strict accordance with Animal Research:
Reporting of In Vivo Experiments (ARRIVE) and Office Laboratory
Animal Welfare (OLAW) NIH guidelines. The protocols were approved by
the local Animal Care Committee of the Fundación Instituto Leloir
(Argentina), Assurance # A5168-01.
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Reagents

Hank’s buffered saline solution (HBSS), trypsin-EDTA, DMEM/F12,
Neurobasal, B27 and Lipofectamine 3000 were purchased from Thermo
Fisher Scientific. Oligomycin, carbonyl cyanide-4-(trifluoromethoxy)
phenylhydrazone (FCCP), antimycin A, rotenone and XF medium were
purchased from Seahorse Bioscience (Agilent). Poly-L-lysine and rapamycin
were purchased from Merck.
Hippocampal primary neuron cultures

Homozygous transgenic McGill-R-Thy1-APP (Tg+/+) rats, harboring the
human APP751 transgene with the Swedish and Indiana mutation under the
control of the murine Thy1.2 promoter, were generated using the HsdBrI:
WH Wistar strain (Leon et al., 2010). Animals were provided to Fundación
Instituto Leloir (FIL) by The Royal Institution for the Advancement of
Learning/McGill University, Montreal, Canada, and an in-house colony was
established at FIL (Galeano et al., 2014). Cultures were performed as
previously described (de Tullio et al., 2013), with minor modifications.
Briefly, 10–12 embryos at E18–19 were extracted from the uterus of
pregnant WT or Tg+/+ rats, and hippocampi were isolated in HBSS buffer.
Tissues were incubated with 2 ml of 0.25% trypsin-EDTA for 20 min at 37°
C and then washed three times with DMEM/F12 supplemented with 10%
FBS. Hippocampi were homogenized in DMEM/F12 mixture
supplemented with 10% FBS by up- and down-pipetting; viability was
assessed using Trypan Blue dye. Cells were plated in p poly-L-lysine-coated
dishes and, after 2 h, medium was replaced by neuronal medium
(Neurobasal, 2 mM L-glutamine, 2% B27, 100 U/ml penicillin, 100 µg/ml
streptomycin). Three days after plating, i.e. at DIV3, cytosine β-Darabinofuranoside (AraC) was added to conditioned medium to a final
concentration of 1 µM to inhibit proliferation of glia cells, yielding neuronal
cultures with 92% purity. Neurons were maintained at 37°C in a humidified
incubator under 5% CO2 until DIV7–9 or DIV14–16.
Immunofluorescence

Neurons were cultured on 12 mm-diameter coverslips and fixed with 4%
PFA at DIV7. Cells were then incubated with the primary antibodies against
βIII tubulin (mouse, 1:1000, Promega) and Tom20 (rabbit,1:500, Santa
Cruz Biotechnology), or glial fibrillary acidic protein (anti-GFAP; rabbit,
1:1000, Dako) overnight at 4°C, followed by incubation with secondary
antibodies labelled with Alexa-Fluor 488 or Alexa-Fluor-546. Neurons were
counterstained with DAPI to label nuclei.
Neuronal expression of Aβ isoforms

To quantify soluble Aβ 38/40/42, the V-PLEX PLUS Aβ Peptide Panel 1
ELISA kit (Meso Scale Diagnostics) was used following the manufacturer’s
instructions. Conditioned media and protein homogenates were loaded in
duplicates onto MULTI-SPOT® microplates pre-coated with antibodies
specific to the C-termini of Aβ38, Aβ40 and Aβ42, and were detected
with SULFO-TAG™-labeled 6E10 antibody. Light emitted upon
electrochemical stimulation was read using the MSD QuickPlex SQ120
instrument. Data were analyzed using MSD Workbench 4.0 software.
Liquid chromatography–mass spectrometry of free fatty acids

Samples were subjected to liquid chromatography–mass spectrometry
LC-MS analysis to detect and quantify levels of free fatty acids in sample
extracts. Fatty acid extraction was carried out on each sample using 100%
methanol as the homogenization solvent. Cell pellets (2×106 cells/sample)
were lysed with 500 μl of methanol and ∼100 μl of zircon beads (0.5 mm).
Methanol extracts were centrifuged (21,000 g for 3 min) and transferred to
glass LC-MS inserts for analysis. The LC column was a Waters TM BEHC18 (2.1×100 mm, 1.7 μm) coupled to a Dionex Ultimate 3000™ system
and the column oven temperature was set to 25°C for gradient elution. The
flow rate was 0.1 ml/min and we used the following buffers: H2O with 0.1%
formic acid (buffer A) and acetonitrile with 0.1% formic acid (buffer B).
The gradient profile was as follows: 60–99% B from 0–6 min, hold at 99% B
from 6–10 min, 99-60% B from 10–11 min, hold at 60% B from 11–15 min.
Injection volume was set to 1 μl for all analyses (15 min total run time
per injection).
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MS analyses were carried out by coupling the LC system to a Thermo Q
Exactive HFTM mass spectrometer operating in heated electrospray
ionization mode (HESI). Data acquisition was over 10 min with a
negative mode full-MS scan ( profile mode) and one microscan, with an
AGC target of 3×106 and a maximum ion time (IT) of 100 ms at 120,000
resolution, with a scan range from 160–400 m/z. Spray voltage was 3.5 kV
and capillary temperature was set to 320°C with a sheath gas rate of 35, aux
gas of 10, and max spray current of 100 μA. The acquisition order of
samples and standard curve points was randomized, with blank matrix
controls before and after each standard curve point to assess carry over (none
detected). The resulting free fatty acid peaks were quantified by measuring
the relative intensities ( peak heights) of the high resolution extracted ion
chromatogram (XIC) for each fatty acid across the samples and external
standard curve samples. All fatty acids were detected as the negative-mode
[M-H]-ion and retention times of the fatty acids were defined using a
cocktail of authentic standards. For each XIC, the theoretical m/z of each
fatty acid (±5 ppm) was used to extract the peak height (24 s retention time
window, 12 s retention time tolerance) as follows: lauric acid (199.1704 m/
z, 2.3 min), myristic acid (227.2017 m/z, 3.1 min), palmitoleic acid
(253.2173 m/z, 3.4 min), palmitic acid (255.2330 m/z, 4.1 min), oleic
acid (281.2486 m/z, 4.4 min), stearic acid (283.2643 m/z, 5.1 min),
arachidic acid (311.2956 m/z, 6.0 min), nervonic acid (365.3425 m/z,
6.9 min), lignoceric acid (367.3582 m/z, 7.5 min). The resulting standard
curve points (in duplicate) were fit to a linear regression (GraphPad Prism7),
and this equation was used to interpolate the concentration of fatty acids in
the sample extracts, as prepared.
Neuronal bioenergetics

Cells (6×104 per well) were plated in Seahorse XFp Cell Culture Miniplates
(Agilent) and maintained in culture until DIV7 when bioenergetics was
assessed. The day of the assay, conditioned medium was aspirated and
replaced by XF Base Medium (Agilent) supplemented with 25 mM
D-glucose, 1 mM sodium pyruvate and 2 mM L-glutamine ( pH 7.4). Cells
were incubated with this medium for 1 h at 37°C in a non-CO2 incubator,
and then the microplate was loaded into Seahorse XFp Analyzer
(Agilent) following manufacturer’s guidelines. Oxygen consumption rate
(OCR) was determined at the beginning of the assay (baseline OCR)
and after the sequential addition of 2 µM oligomycin, 1 µM FCCP and
0.5 µM rotenone+antimycin A. In general, four baseline rates and three
response rates (after the addition of a compound) were measured and the
average of these rates used for data analysis. Neurons were titrated with
0.125–2 µM FCCP and 1 µM FCCP rendered the maximum OCR, so this
concentration was used for the experiments. Non-mitochondrial OCR was
determined after the addition of 0.5 µM rotenone+antimycin A and
subtracted from all other values before calculation of the respiratory
parameters as previously described (Martino Adami et al., 2017).
Respiratory parameters were obtained as follows: basal respiration,
baseline OCR; respiration driving proton leak, OCR after the addition of
2 mM oligomycin; respiration driving ATP synthesis, basal respiration –
respiration driving proton leak; maximum respiration, OCR after the
addition of 1 mM FCCP; respiratory control ratio (RCR), maximum
respiration/respiration driving proton leak; spare respiratory capacity,
maximum respiration – basal respiration; coupling efficiency, respiration
driving ATP synthesis/basal respiration.
Plasmids and transfections

Neurons were plated on 25 mm-diameter coverslips and transfected at DIV5
using Lipofectamine 3000 (Thermo Fisher Scientific) with AKAP1-FKBPYFP and CFP-FRB-ER (short linkers) or AKAP1-18×-FKBP-YFP and CFPER-9×-FRB (long linkers) plasmids. The mouse AKAP1 N-terminal sequence
(residues 34–63: 5′-MAIQLRSLFPLALPGLLALLGWWWFFSRKK-3′)
targets the outer mitochondrial membrane (OMM), and the mouse Sac1 C-terminal sequence (residues 260–326). 5′-FLALPIIMVVAFSMCIICLLMAGDTWTETLAYVLFWGVASIGTFFIILYNGKDFVDAPRLVQKEKID-3′)
the ER. The rapamycin-inducible heterodimerization domains FKBP and FRB
(Ho et al., 1996) were fused to the AKAP1 and Sac1 sequences, respectively,
through repetitive sequences that act like arms, with a longer repetitive sequence for the long linkers and a shorter one for the short linkers. FKBP and FRB
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domains were also fused to fluorescent proteins YFP and CFP, respectively,
which can form a FRET pair.
Multicolor live cell imaging

Forty-eight hours after transfection (DIV7), neuronal medium was replaced by
imaging medium, composed of 50% fresh neuronal culture medium
(Neurobasal, 2 mM L-glutamine, 2% B27, 100 U/ml penicillin, 100 µg/ml
streptomycin) and 50% extracellular medium (ECM; 120 mM NaCl, 5 mM
NaHCO3, 10 mM Na-HEPES, 4.7 mM KCl, 1.2 mM KH2PO4, 1.2 mM
MgSO4, 2 mM CaCl2, 10 mM glucose 0.25% BSA, pH 7.4). Wide-field
fluorescence was recorded at 37°C with a ProEM1024 EM-CCD camera
(Princeton Instruments) coupled to an epi-fluorescence inverted Leica DMI
6000B microscope with a 40×/NA 1.35 oil immersion objective (Olympus).
The following filters were used: YFP (excitation: 495/20, emission: 532/54),
CFP (excitation: 415/30, emission: 502/38) and FRET (excitation: 415/30,
emission: 532/54). Each triplet was obtained every 3 s (to avoid
photobleaching) during 7 min 30 s (150 images). Rapamycin (100 nM) was
added after the first 60 s to induce the increase in FRET signal. Fluorescence
was expressed as the FRET:CFP ratio after background subtraction of each
individual wavelength using Spectralyzer software (Thomas Jefferson
University, Philadelphia,). An average of ten measurements before the
addition of rapamycin was subtracted from all other values of each individual
experiment to normalize to basal FRET fluorescence.
Transmission electron microscopy

Neurons were plated on 15 mm-diameter coverslips until DIV7 or DIV14 and
were fixed in cold 2% glutaraldehyde overnight. The following day, they were
fixed in 1% osmium tetroxide, contrasted with 1% uranyl acetate, dehydrated
with increasing ethanol concentrations and embedded in Durcupan. Blocks
were immersed in liquid nitrogen to release the coverslips and were then sliced
into ultrathin sections. Sections were analyzed with a transmission electron
microscope (Hitachi 7000). Gap width, interface length and mitochondrial
perimeter analyses were performed using a macro for the image-processing
package Fiji (Thomas Jefferson University, Philadelphia, PA; Weaver et al.,
2017); the ER lumen area was analyzed with ImageJ.
Neuronal mitochondria isolation

Hippocampal primary neuronal cultures were prepared as described above.
After DIV7, cells were detached and mitochondria isolated by differential
centrifugation following standard procedures (Cadenas et al., 1980). Briefly,
neurons were homogenized with a manual Teflon glass homogenizer in icecold MSTE buffer (0.23 M mannitol, 0.07 M sucrose, 10 mM Tris-HCl,
1 mM EDTA pH 7.4). Homogenates were centrifuged at 600 g for 10 min to
discard cell debris and nuclei, and then supernatants were centrifuged at
8000 g to obtain crude mitochondrial pellets. Protein concentration was
determined using the Pierce BCA Protein Assay Kit (Thermo Fisher
Scientific).
Western blotting

Samples (10 μg/lane) were run on SDS-tricine 12.5% gels and transferred to a
PVDF membrane. The membrane was blocked with 5% skimmed milk in
PBS-Tween 0.01% for 1 h at room temperature and incubated overnight at 4°C
with rabbit anti-Tom20 (1:500, Santa Cruz Biotechnology). Peroxidaseconjugated secondary antibody and enhanced chemiluminescence detection
system (ECL, Thermo Fisher Scientific) were used to detect immunoreactivity,
which was quantitated with a STORM 840 Phosphor Imager (GE Healthcare).
Liquid Chromatography with tandem mass spectrometry in
lipidomics

Mitochondrial samples (10 µg) were subjected to liquid chromatography–
mass spectrometry (LC-MS) analysis to detect and identify phospholipid
molecules, and quantify the relative levels of identified lipids. Lipid
extraction was carried out on each sample based on the method by Vorkas
et al. (2015a,b). The dried samples were resolubilized in 10 μl of a
isopropanol:acetonitrile:H2O (4:3:1) mixture and analyzed by ultraperformance liquid chromatography–tandem mass spectrometery (UPLCMS/MS) with a polarity switching method modified from Vorkas et al.
(2015a,b). The LC column was a Waters TM CSH-C18 (2.1×100 mm,
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1.7 μm) coupled to a Dionex Ultimate 3000™ system, the column oven
temperature was set to 55°C for the gradient elution. A flow rate of 0.3 ml/
min was used with, buffer A: acetonitrile:H2O (60:40), 10 mM ammonium
formate, 0.1% formic acid and, buffer B: 90:10 isopropanol:acetonitrile,
10 mM ammonium formate, 0.1% formic acid. The gradient profile was as
follows: 40–43% buffer B (0–1.25 min), 43–50% buffer B (1.25–2 min),
50–54% buffer B (2–11 min), 54–70% buffer B (11–12 min), 70–99%
buffer B (12–18 min), 70–99% buffer B (18–32 min), 99–40% buffer B
(23–24 min), hold 40% buffer B (1 min). Injection volume was set to 1 μl
for all analyses (25 min total run time per injection). MS analyses were
carried out by coupling the LC system to a Thermo Q Exactive HFTM mass
spectrometer operating in heated electrospray ionization mode (HESI).
Method duration was 20 min with a polarity switching data-dependent Top
10 method for both positive and negative modes. Spray voltage for both
positive and negative modes was 3.5 kV and capillary temperature was set to
320°C with a sheath gas rate of 35, auxiliary gas of 10, and maximum spray
current of 100 μA. The full MS scan for both polarities utilized 120,000
resolution with an AGC target of 3×106 and a maximum IT of 100 ms, and
the scan range was from 350–2000 m/z. MS/MS spectra for both positive
and negative mode used a resolution of 15,000, AGC target of 1×105,
maximum IT of 50 ms, isolation window of 0.4 m/z, isolation offset of
0.1 m/z, fixed first mass of 50 m/z, and three-way multiplexed normalized
collision energies (nCE) of 10, 35 and 80. The minimum AGC target was
5×104 with an intensity threshold of 1×106. All data were acquired in profile
mode and normalized to protein levels.
Statistical analysis

Data were expressed as the mean±s.e.m. of at least three independent
experiments. Mean differences were analyzed using unpaired or paired
Student’s t-test or two-way ANOVA. Assumptions of normality and
homoscedasticity were assessed using the D’Agostino-Pearson omnibus
normality test and the F-test of equality of variances, respectively. In some
cases the assumption of homoscedasticity was violated and data were
analyzed using Welch’s unequal variances t-test. Significance level was set
at P<0.05. Two-tailed probabilities were always reported. Statistical analysis
was performed using GraphPad Prism 6 software (GraphPad software, Inc,
La Jolla, CA).
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Janikiewicz, J., Szymań ski, J., Malinska, D., Patalas-Krawczyk, P., Michalska,
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